Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]

ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance

Prof Heather Payne and Dr Jochen Walz

ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance ( Prof Heather Payne and Dr Jochen Walz )

Haemopathy burden in the National Cancer Center of Cambodia

Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia

Haemopathy burden in the National Cancer Center of Cambodia ( Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia )

Choosing wisely in multiple myeloma

Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal

Choosing wisely in multiple myeloma ( Dr Bishesh Poudyal - Civil Service Hospital, Kathmandu, Nepal )

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy...

Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free...

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable...

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Intravesical IO using durvalumab shows promising results for patients with high...

Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece

Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )

Surgical technique remains the most important factor associated with recovery...

Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada

Surgical technique remains the most important factor associated with recovery of urinary continence after radical prostatectomy ( Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada )

How to avoid unnecessary second surgery in differentiated thyroid cancer

Dr Sarameth Thou - Calmette Hospital, Phnom Penh, Cambodia

How to avoid unnecessary second surgery in differentiated thyroid cancer ( Dr Sarameth Thou - Calmette Hospital, Phnom Penh, Cambodia )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

Single-dose IORT during lumpectomy for breast cancer an innovative patient...

Dr Jayant Vaidya - University College London, London, UK

Single-dose IORT during lumpectomy for breast cancer an innovative patient-centred treatment ( Dr Jayant Vaidya - University College London, London, UK )

More from ecancer